Aradigm Corporation's IPO

Aradigm Corporation raised a round of funding on July 09, 1996. Investors include Public.

Aradigm is an emerging specialty pharmaceutical company developing and commercializing a portfolio of drugs delivered by inhalation for the treatment of severe respiratory disease. Bolstered by its de…

Articles about Aradigm Corporation's IPO: